$PSBD
Palmer Square Capital BDC Inc. Stock $psbd

$psbd Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024066323 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$15.73M	$15.76M
YoY Change	6.25%	10.97%
Cost Of Revenue	$20.32M	$19.70M
YoY Change	48.37%
Gross Profit	$16.98M	$16.85M
YoY Change	12.64%
Gross Profit Margin	107.96%	106.95%
Selling, General & Admin	$1.253M	$1.095M
YoY Change	129.32%
% of Gross Profit	7.38%	6.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$21.58M	$20.79M
YoY Change	51.48%	54.04%
Operating Profit	-$4.596M	-$3.939M
YoY Change	-653.1%	-70.25%
Interest Expense	-$8.174M	-$10.45M
YoY Change	-171.07%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$7.555M	$5.313M
YoY Change	-77.68%
Income Tax
% Of Pretax Income
Net Earnings	$7.555M	$5.313M
YoY Change	-77.68%	-77.81%
Net Earnings / Revenue	48.03%	33.72%
Basic Earnings Per Share	$0.48	$0.48
Diluted Earnings Per Share	$0.48	$0.48
COMMON SHARES
Basic Shares Outstanding	32.62M shares	32.57M shares
Diluted Shares Outstanding	32.61M	32.57M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.786M	$14.79M
YoY Change	-47.64%
Cash & Equivalents	$1.786M	$14.79M
Short-Term Investments
Other Short-Term Assets	$139.5K	$167.1K
YoY Change	-77.51%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$11.68M	$15.91M
YoY Change	-6.89%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.390B	$1.432B
YoY Change	25.81%
Other Assets
YoY Change
Total Long-Term Assets	$1.402B	$1.443B
YoY Change	26.04%
TOTAL ASSETS
Total Short-Term Assets	$11.68M	$15.91M
Total Long-Term Assets	$1.402B	$1.443B
Total Assets	$1.414B	$1.459B
YoY Change	25.67%	34.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.12M	$68.24M
YoY Change	-25.86%
Accrued Expenses	$1.093M	$1.314M
YoY Change	21.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00
YoY Change
Total Short-Term Liabilities	$47.20M	$89.56M
YoY Change	3.98%
LONG-TERM LIABILITIES
Long-Term Debt	$824.4M	$820.4M
YoY Change	30.33%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$824.4M	$820.4M
YoY Change	30.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.20M	$89.56M
Total Long-Term Liabilities	$824.4M	$820.4M
Total Liabilities	$871.6M	$910.0M
YoY Change	28.57%	38.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$69.58M	-$61.80M
YoY Change	4.77%
Common Stock	$611.5M	$610.6M
YoY Change	2293137.28%	2369005.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$541.9M	$548.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.414B	$1.459B
YoY Change	25.67%	34.87%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$7.555M	$5.313M
YoY Change	-77.68%	-77.81%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$3.510M	-$513.5K
YoY Change	-78.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-16.51M	7.047M
YoY Change	14.86%
NET CHANGE
Cash From Operating Activities	3.510M	-513.5K
Cash From Investing Activities
Cash From Financing Activities	-16.51M	7.047M
Net Change In Cash	-13.00M	6.534M
YoY Change	-838.89%
FREE CASH FLOW
Cash From Operating Activities	$3.510M	-$513.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	234303	usd
CY2024Q2	us-gaap	Other Income OtherIncome	283918	usd
CY2023Q2	us-gaap	Other Income OtherIncome	133227	usd
	us-gaap	Other Income OtherIncome	554206	usd
	us-gaap	Other Income OtherIncome	189122	usd
CY2024Q2	us-gaap	Investment Income Net InvestmentIncomeNet	36549496	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	27441864	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	71334439	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56126
	dei	Entity Registrant Name EntityRegistrantName	Palmer Square Capital BDC Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3665200
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1900 Shawnee Mission Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 315
	dei	Entity Address City Or Town EntityAddressCityOrTown	Mission Woods
	dei	Entity Address State Or Province EntityAddressStateOrProvince	KS
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	66205
	dei	City Area Code CityAreaCode	(816)
	dei	Local Phone Number LocalPhoneNumber	994-3200
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	PSBD
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32623979	shares
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1474597939	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1159135422	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1431576768	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1108810753	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14788774	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2117109	usd
CY2024Q2	us-gaap	Receivable Investment Sale ReceivableInvestmentSale	15048	usd
CY2023Q4	us-gaap	Receivable Investment Sale ReceivableInvestmentSale	97141	usd
CY2024Q2	psbd	Receivable For Paydowns Of Investments ReceivableForPaydownsOfInvestments	637142	usd
CY2023Q4	psbd	Receivable For Paydowns Of Investments ReceivableForPaydownsOfInvestments	344509	usd
CY2024Q2	psbd	Due From Investment Adviser DueFromInvestmentAdviser	39589	usd
CY2023Q4	psbd	Due From Investment Adviser DueFromInvestmentAdviser	1718960	usd
CY2024Q2	us-gaap	Dividends Receivable DividendsReceivable	263924	usd
CY2023Q4	us-gaap	Dividends Receivable DividendsReceivable	301637	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	11252844	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	8394509	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	167101	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	30100	usd
CY2024Q2	us-gaap	Assets Assets	1458741190	usd
CY2023Q4	us-gaap	Assets Assets	1121814718	usd
CY2024Q2	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	6174013	usd
CY2023Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	3211510	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	519866053	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	641828805	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1793514	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1793514	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	300524027	usd
CY2024Q2	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	68240383	usd
CY2023Q4	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	14710524	usd
CY2024Q2	us-gaap	Distribution Payable DistributionPayable	15306680	usd
CY2024Q2	us-gaap	Management Fee Payable ManagementFeePayable	2450079	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	2252075	usd
CY2024Q2	us-gaap	Incentive Fee Payable IncentiveFeePayable	2249954	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1313783	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1067921	usd
CY2024Q2	us-gaap	Liabilities Liabilities	909950959	usd
CY2023Q4	us-gaap	Liabilities Liabilities	659859325	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32567405	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32567405	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27102794	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27102794	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	32567	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	27103	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	610557076	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	520663106	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61799412	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58734816	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	548790231	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	461955393	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1458741190	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1121814718	usd
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.85
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	17.04
CY2024Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	35278431	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	26166621	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	68486203	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	51619359	usd
CY2024Q2	us-gaap	Investment Income Dividend InvestmentIncomeDividend	805031	usd
CY2023Q2	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1142016	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2059727	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1818884	usd
CY2024Q2	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	182116	usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	234303	usd
CY2024Q2	us-gaap	Other Income OtherIncome	283918	usd
CY2023Q2	us-gaap	Other Income OtherIncome	133227	usd
	us-gaap	Other Income OtherIncome	189122	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	27441864	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	71334439	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	53627365	usd
CY2024Q2	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	36549496	usd
CY2023Q2	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	27441864	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	71334439	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	53627365	usd
CY2024Q2	us-gaap	Incentive Fee Expense IncentiveFeeExpense	2249954	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	4174706	usd
CY2024Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	14997028	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	53627365	usd
CY2023Q2	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	27441864	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	71334439	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	53627365	usd
CY2024Q2	us-gaap	Incentive Fee Expense IncentiveFeeExpense	2249954	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	4174706	usd
CY2024Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	14997028	usd
CY2023Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	10874884	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	28175858	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	21197013	usd
CY2024Q2	us-gaap	Management Fee Expense ManagementFeeExpense	2450079	usd
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	2046014	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	4866318	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	3958241	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	398080	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	207282	usd
	us-gaap	Professional Fees ProfessionalFees	636023	usd
	us-gaap	Professional Fees ProfessionalFees	419276	usd
CY2024Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	37295	usd
CY2023Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	18699	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	74590	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	37192	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	659209	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	350618	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1381375	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	717624	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	20791645	usd
	us-gaap	Operating Expenses OperatingExpenses	39308870	usd
	us-gaap	Operating Expenses OperatingExpenses	26329346	usd
CY2023Q2	us-gaap	Other Operating Income OtherOperatingIncome	255752	usd
	us-gaap	Other Operating Income OtherOperatingIncome	50511	usd
	us-gaap	Other Operating Income OtherOperatingIncome	494780	usd
CY2024Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-20791645	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-13241745	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-39258359	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-25834566	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	15757851	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	14200119	usd
	us-gaap	Net Investment Income NetInvestmentIncome	32076080	usd
	us-gaap	Net Investment Income NetInvestmentIncome	27792799	usd
CY2024Q2	psbd	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-9411924	usd
CY2023Q2	psbd	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-2570	usd
	psbd	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-11148255	usd
	psbd	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-320015	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-9411924	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2570	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-320015	usd
CY2024Q2	psbd	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	1033114	usd
CY2023Q2	psbd	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-9743113	usd
	psbd	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-7265128	usd
	psbd	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-24556200	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1033114	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9743113	usd
CY2023Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	10874884	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	21197013	usd
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	2046014	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	4866318	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	398080	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	207282	usd
	us-gaap	Professional Fees ProfessionalFees	636023	usd
	us-gaap	Professional Fees ProfessionalFees	419276	usd
CY2024Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	37295	usd
CY2023Q2	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	18699	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	74590	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	37192	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	659209	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	350618	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1381375	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	717624	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	20791645	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	13497497	usd
	us-gaap	Operating Expenses OperatingExpenses	39308870	usd
	us-gaap	Operating Expenses OperatingExpenses	26329346	usd
CY2023Q2	us-gaap	Other Operating Income OtherOperatingIncome	255752	usd
	us-gaap	Other Operating Income OtherOperatingIncome	50511	usd
	us-gaap	Other Operating Income OtherOperatingIncome	494780	usd
CY2024Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-20791645	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-13241745	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-39258359	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-25834566	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	15757851	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	14200119	usd
	us-gaap	Net Investment Income NetInvestmentIncome	32076080	usd
	us-gaap	Net Investment Income NetInvestmentIncome	27792799	usd
CY2024Q2	psbd	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-9411924	usd
CY2023Q2	psbd	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-2570	usd
	psbd	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-11148255	usd
	psbd	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-320015	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-9411924	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2570	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11148255	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-320015	usd
CY2024Q2	psbd	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	1033114	usd
CY2023Q2	psbd	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-9743113	usd
	psbd	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-7265128	usd
	psbd	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-24556200	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1033114	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9743113	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7265128	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	24556200	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-10445038	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	9740543	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3883127	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	24236185	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	5312813	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	23940662	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7265128	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	24556200	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-10445038	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	9740543	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3883127	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	24236185	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	5312813	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	23940662	usd
	us-gaap	Net Income Loss NetIncomeLoss	28192953	usd
	us-gaap	Net Income Loss NetIncomeLoss	52028984	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.16
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.94
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.88
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32569280	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25453970	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32081916	shares
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	15757851	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	14200119	usd
	us-gaap	Net Investment Income NetInvestmentIncome	32076080	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-9411924	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2570	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11148255	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-320015	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1033114	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	24556200	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	5312813	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	23940662	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	28192953	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	52028984	usd
CY2024Q2	psbd	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-15306680	usd
CY2023Q2	psbd	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-13183368	usd
	psbd	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-31257549	usd
	psbd	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-13183368	usd
CY2024Q2	psbd	Distributions Declared From Realized Gains DistributionsDeclaredFromRealizedGains	-15306680	usd
CY2023Q2	psbd	Distributions Declared From Realized Gains DistributionsDeclaredFromRealizedGains	-13183368	usd
	psbd	Distributions Declared From Realized Gains DistributionsDeclaredFromRealizedGains	-31257549	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6200000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	89652500	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	593206	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	6935473	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	346272	usd
CY2024Q2	psbd	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	246934	usd
CY2023Q2	psbd	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	13135473	usd
	psbd	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	89899434	usd
	psbd	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	24239698	usd
CY2024Q2	psbd	Increase Decrease In Net Assets IncreaseDecreaseInNetAssets	-9746933	usd
CY2023Q2	psbd	Increase Decrease In Net Assets IncreaseDecreaseInNetAssets	23892767	usd
	psbd	Increase Decrease In Net Assets IncreaseDecreaseInNetAssets	86834838	usd
	psbd	Increase Decrease In Net Assets IncreaseDecreaseInNetAssets	63085314	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	558537164	usd
	us-gaap	Net Income Loss NetIncomeLoss	28192953	usd
	us-gaap	Net Income Loss NetIncomeLoss	52028984	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.16
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.94
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.88
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.08
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32569280	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25453970	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32081916	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25025158	shares
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	15757851	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	14200119	usd
	us-gaap	Net Investment Income NetInvestmentIncome	32076080	usd
	us-gaap	Net Investment Income NetInvestmentIncome	27792799	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-9411924	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2570	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-320015	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1033114	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9743113	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7265128	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	24556200	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	5312813	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	23940662	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	28192953	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	52028984	usd
CY2024Q2	psbd	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-15306680	usd
	psbd	Dividends And Distributions To Stockholders DividendsAndDistributionsToStockholders	-13183368	usd
CY2024Q2	psbd	Distributions Declared From Realized Gains DistributionsDeclaredFromRealizedGains	-15306680	usd
CY2023Q2	psbd	Distributions Declared From Realized Gains DistributionsDeclaredFromRealizedGains	-13183368	usd
	psbd	Distributions Declared From Realized Gains DistributionsDeclaredFromRealizedGains	-31257549	usd
	psbd	Distributions Declared From Realized Gains DistributionsDeclaredFromRealizedGains	-13183368	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6200000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	89652500	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17304225	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	593206	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	6935473	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	593206	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	6935473	usd
CY2024Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	346272	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	346272	usd
CY2024Q2	psbd	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	246934	usd
CY2023Q2	psbd	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	13135473	usd
	psbd	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	89899434	usd
	psbd	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	24239698	usd
CY2024Q2	psbd	Increase Decrease In Net Assets IncreaseDecreaseInNetAssets	-9746933	usd
	psbd	Increase Decrease In Net Assets IncreaseDecreaseInNetAssets	86834838	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	558537164	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	461955393	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	363443482	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	402636029	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	461955393	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	363443482	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	548790231	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	426528796	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	548790231	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	426528796	usd
	us-gaap	Net Income Loss NetIncomeLoss	28192953	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11148255	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-320015	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7265128	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	24556200	usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	234303	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	547865017	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	360234199	usd
	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	535784227	usd
	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	110130547	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	548565867	usd
	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	209583349	usd
	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	135954079	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	698939	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	494302	usd
	psbd	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	-82093	usd
	psbd	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	-31014356	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	2820622	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	1366204	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-1679371	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	21650	usd
	psbd	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	292633	usd
	psbd	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	475531	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	137001	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2603082	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	736352	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	53529859	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-17988152	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	198004	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	173199	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	245862	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	187900000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10500000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	305319060	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	27500000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	300000000	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	15950869	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	13188961	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	89652500	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17304225	usd
	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	593206	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	251074549	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12671665	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5085787	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2117109	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1650801	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14788774	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6736588	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	548790231	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	548790231	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	426528796	usd
	us-gaap	Net Income Loss NetIncomeLoss	28192953	usd
	us-gaap	Net Income Loss NetIncomeLoss	52028984	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11148255	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-320015	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7265128	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	24556200	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	914811	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	856346	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	547865017	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	360234199	usd
	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	110130547	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	548565867	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	313870724	usd
	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	209583349	usd
	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	135954079	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	698939	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	494302	usd
	psbd	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	-82093	usd
	psbd	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	-31014356	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	2820622	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	1366204	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-1679371	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	21650	usd
	psbd	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	292633	usd
	psbd	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	475531	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2603082	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	736352	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2586844	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	53529859	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-17988152	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	198004	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	173199	usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	2249954	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	245862	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-214987	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-238402884	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17995605	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	187900000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	305319060	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	27500000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	300000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5454956	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	25082	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	15950869	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	13188961	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	89652500	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17304225	usd
	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	593206	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	346272	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	251074549	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12909818	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12671665	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5085787	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2117109	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1650801	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14788774	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6736588	usd
	us-gaap	Interest Paid Net InterestPaidNet	27439506	usd
	us-gaap	Interest Paid Net InterestPaidNet	18610169	usd
	psbd	Reinvestment Of Distributions During The Period ReinvestmentOfDistributionsDuringThePeriod	6935473	usd
	psbd	Distributions Payable DistributionsPayable	15306680	usd
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1474597939	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1431576768	usd
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	2.609	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates.</span></p>
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Indemnifications</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company enters into contracts that contain a variety of representations which provide general indemnifications. The Company’s maximum exposure under these arrangements cannot be known; however, the Company expects any risk of loss to be remote.</span></p>
	us-gaap	Interest Paid Net InterestPaidNet	27439506	usd
	us-gaap	Interest Paid Net InterestPaidNet	18610169	usd
	psbd	Distributions Declared During The Period DistributionsDeclaredDuringThePeriod	31257549	usd
	psbd	Distributions Declared During The Period DistributionsDeclaredDuringThePeriod	13183368	usd
	psbd	Reinvestment Of Distributions During The Period ReinvestmentOfDistributionsDuringThePeriod	6935473	usd
	psbd	Distributions Payable DistributionsPayable	15306680	usd
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1474597939	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1431576768	usd
CY2024Q2	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	2.609	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates.</span></p>
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Indemnifications</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company enters into contracts that contain a variety of representations which provide general indemnifications. The Company’s maximum exposure under these arrangements cannot be known; however, the Company expects any risk of loss to be remote.</span></p>
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.90	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.90	pure
	us-gaap	Quarterly Financial Information Income Taxes Significant Variation Description QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription	In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one year period ending October 31 in such calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income.
	psbd	Renewed Period RenewedPeriod	P2Y
	us-gaap	Quarterly Financial Information Income Taxes Significant Variation Description QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription	In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one year period ending October 31 in such calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income.
	psbd	Renewed Period RenewedPeriod	P2Y
	psbd	Weighted Average Number Of Share Outstanding Percentage WeightedAverageNumberOfShareOutstandingPercentage	0.0175	pure
	us-gaap	Management And Service Fees Rate ManagementAndServiceFeesRate	0.02	pure
	psbd	Maximum Annual Rate For Management And Service Fees MaximumAnnualRateForManagementAndServiceFees	0.0175	pure
CY2024Q2	psbd	Hurdle Rate Percentage In Each Quarter HurdleRatePercentageInEachQuarter	0.015	pure
CY2024Q2	psbd	Hurdle Rate Percentage In Annual Term HurdleRatePercentageInAnnualTerm	0.06	pure
CY2024Q2	psbd	Percentage Of Adjusted Net Investment Income PercentageOfAdjustedNetInvestmentIncome	1	pure
	psbd	Weighted Average Number Of Share Outstanding Percentage WeightedAverageNumberOfShareOutstandingPercentage	0.0175	pure
	us-gaap	Management And Service Fees Rate ManagementAndServiceFeesRate	0.02	pure
	psbd	Maximum Annual Rate For Management And Service Fees MaximumAnnualRateForManagementAndServiceFees	0.0175	pure
CY2024Q2	psbd	Hurdle Rate Percentage In Each Quarter HurdleRatePercentageInEachQuarter	0.015	pure
CY2024Q2	psbd	Hurdle Rate Percentage In Annual Term HurdleRatePercentageInAnnualTerm	0.06	pure
CY2024Q2	psbd	Percentage Of Adjusted Net Investment Income PercentageOfAdjustedNetInvestmentIncome	1	pure
CY2024Q2	psbd	Catch Up Amount Determining Percentage CatchUpAmountDeterminingPercentage	0.017142	pure
CY2024Q2	psbd	Incentive Fee Percentage IncentiveFeePercentage	0.125	pure
CY2024Q2	psbd	Incentive Fee Percentage Equals Adjusted Net Investment Income IncentiveFeePercentageEqualsAdjustedNetInvestmentIncome	0.125	pure
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1474597939	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1108810753	usd
	psbd	Investment Company Portfolio Turnover Longterm Investment InvestmentCompanyPortfolioTurnoverLongtermInvestment	0.171	pure
	psbd	Investment Company Portfolio Turnover At Fair Value InvestmentCompanyPortfolioTurnoverAtFairValue	0.173	pure
CY2023	psbd	Investment Company Portfolio Turnover Longterm Investment InvestmentCompanyPortfolioTurnoverLongtermInvestment	0.142	pure
CY2023	psbd	Investment Company Portfolio Turnover At Fair Value InvestmentCompanyPortfolioTurnoverAtFairValue	0.141	pure
CY2024Q2	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2023Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2024Q2	us-gaap	Investments Investments	1431576768	usd
CY2023Q4	us-gaap	Investments Investments	1108810753	usd
	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	1.50	pure
	psbd	Total Secured Note Principal Outstanding TotalSecuredNotePrincipalOutstanding	300000000	usd
	psbd	Subordinated Notes Principal Outstanding SubordinatedNotesPrincipalOutstanding	100500000	usd
	psbd	Description Of Subordinated Notes Credit Rating DescriptionOfSubordinatedNotesCreditRating	Not rated
	psbd	Principal Outstanding PrincipalOutstanding	400500000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5485963	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5485963	shares
CY2024Q2	psbd	Catch Up Amount Determining Percentage CatchUpAmountDeterminingPercentage	0.017142	pure
CY2024Q2	psbd	Incentive Fee Percentage IncentiveFeePercentage	0.125	pure
CY2024Q2	psbd	Incentive Fee Percentage Equals Adjusted Net Investment Income IncentiveFeePercentageEqualsAdjustedNetInvestmentIncome	0.125	pure
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1474597939	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1431576768	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1159135422	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1108810753	usd
	psbd	Investment Company Portfolio Turnover Longterm Investment InvestmentCompanyPortfolioTurnoverLongtermInvestment	0.171	pure
	psbd	Investment Company Portfolio Turnover At Fair Value InvestmentCompanyPortfolioTurnoverAtFairValue	0.173	pure
CY2023	psbd	Investment Company Portfolio Turnover Longterm Investment InvestmentCompanyPortfolioTurnoverLongtermInvestment	0.142	pure
CY2023	psbd	Investment Company Portfolio Turnover At Fair Value InvestmentCompanyPortfolioTurnoverAtFairValue	0.141	pure
CY2024Q2	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2023Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2024Q2	us-gaap	Investments Investments	1431576768	usd
CY2023Q4	us-gaap	Investments Investments	1108810753	usd
	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	1.50	pure
	psbd	Total Secured Note Principal Outstanding TotalSecuredNotePrincipalOutstanding	300000000	usd
	psbd	Subordinated Notes Principal Outstanding SubordinatedNotesPrincipalOutstanding	100500000	usd
	psbd	Description Of Subordinated Notes Credit Rating DescriptionOfSubordinatedNotesCreditRating	Not rated
	psbd	Principal Outstanding PrincipalOutstanding	400500000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5485963	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5485963	shares
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	90200000	usd
	psbd	Aggregate Purchase Prices AggregatePurchasePrices	5000000	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	90200000	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	90200000	usd
	psbd	Aggregate Purchase Prices AggregatePurchasePrices	5000000	usd
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	149382	shares
CY2024Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	16.49
CY2024Q2	psbd	Aggregate Unfunded Commitments AggregateUnfundedCommitments	30000000	usd
CY2024Q2	psbd	Unfunded Commitments UnfundedCommitments	29997295	usd
CY2023Q4	psbd	Unfunded Commitments UnfundedCommitments	20107358	usd
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	17.04
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.96
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.23
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	1
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	149382	shares
CY2024Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	16.49
CY2024Q2	psbd	Aggregate Unfunded Commitments AggregateUnfundedCommitments	30000000	usd
CY2023Q4	psbd	Aggregate Unfunded Commitments AggregateUnfundedCommitments	20100000	usd
CY2024Q2	psbd	Unfunded Commitments UnfundedCommitments	29997295	usd
CY2023Q4	psbd	Unfunded Commitments UnfundedCommitments	20107358	usd
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	17.04
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.96
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.11
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.23
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	2.11
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.96
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.52
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	0.77
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	2.11
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.96
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.52
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.96
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.85
CY2024Q2	us-gaap	Shares Outstanding SharesOutstanding	32567405	shares
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	25772963	shares
CY2024Q2	us-gaap	Assets Net AssetsNet	548790231	usd
	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	32081916	shares
	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	25025158	shares
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0473	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1411	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.17	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.11	pure
	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.1428	pure
	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.133	pure
	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.1426	pure
	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.1305	pure
	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.1164	pure
	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.1379	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.1166	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.1404	pure
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.47
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense		usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.11
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.16
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.88
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.94
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.08
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25025158	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25453970	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32081916	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32569280	shares
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind		usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.96
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.52
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.85
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.55
CY2024Q2	us-gaap	Shares Outstanding SharesOutstanding	32567405	shares
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	25772963	shares
CY2024Q2	us-gaap	Assets Net AssetsNet	548790231	usd
CY2023Q2	us-gaap	Assets Net AssetsNet	426528796	usd
	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	32081916	shares
	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	25025158	shares
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0473	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1411	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.17	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.11	pure
	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.1428	pure
	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.133	pure
	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.1426	pure
	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.1305	pure
	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.1164	pure
	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.1379	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.1166	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.1404	pure
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.47
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q4	us-gaap	Incentive Fee Payable IncentiveFeePayable		usd
CY2023Q2	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind		usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind		usd
CY2023Q2	us-gaap	Incentive Fee Expense IncentiveFeeExpense		usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense		usd
CY2024Q2	us-gaap	Other Operating Income OtherOperatingIncome		usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.48
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.11
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.16
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.88
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.94
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32569280	shares
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind		usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	psbd	Reinvestment Of Distributions During The Period ReinvestmentOfDistributionsDuringThePeriod		usd
	psbd	Distributions Payable DistributionsPayable		usd
	psbd	Additional Renewed Period AdditionalRenewedPeriod	P1Y
	psbd	Subordinated Notes Interest Rate Spread Over Secured Overnight Financing Rate SubordinatedNotesInterestRateSpreadOverSecuredOvernightFinancingRate
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001794776
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
	psbd	Reinvestment Of Distributions During The Period ReinvestmentOfDistributionsDuringThePeriod		usd
	psbd	Additional Renewed Period AdditionalRenewedPeriod	P1Y
	psbd	Subordinated Notes Interest Rate Spread Over Secured Overnight Financing Rate SubordinatedNotesInterestRateSpreadOverSecuredOvernightFinancingRate
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001794776

Files In Submission

Name	View Source	Status
0001213900-24-066323-index-headers.html	Edgar Link	pending
0001213900-24-066323-index.html	Edgar Link	pending
0001213900-24-066323.txt	Edgar Link	pending
0001213900-24-066323-xbrl.zip	Edgar Link	pending
ea0209976-10q_palmer.htm	Edgar Link	pending
ea020997601ex31-1_palmer.htm	Edgar Link	pending
ea020997601ex31-2_palmer.htm	Edgar Link	pending
ea020997601ex32-1_palmer.htm	Edgar Link	pending
ea020997601ex32-2_palmer.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
psbd-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
psbd-20240630_cal.xml	Edgar Link	unprocessable
psbd-20240630_pre.xml	Edgar Link	unprocessable
ea0209976-10q_palmer_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
psbd-20240630_def.xml	Edgar Link	unprocessable
psbd-20240630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PSBD
Palmer Square Capital BDC Inc. Stock $psbd

2024 Q3 Form 10-Q Financial Statement

#000121390024066323 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PSBD Palmer Square Capital BDC Inc. Stock $psbd

2024 Q3 Form 10-Q Financial Statement

#000121390024066323 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PSBD
Palmer Square Capital BDC Inc. Stock $psbd